Sinopharm Group Co., Ltd. (X2S)
Market Open
11 Aug, 06:03
XFRA 
€
1. 84
-0.07
-3.5125%
€
6.69B Market Cap
6.6 P/E Ratio
6.89% Div Yield
1,400 Volume
0 Eps
€ 1.91
Previous Close Want to track X2S and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sinopharm Group Co., Ltd. (X2S) Statistics
Valuation metrics
Market Cap 6.69B
Enterprise value 9.89B
Trailing P/E (ttm) 7.39
Forward P/E -
PEG ratio -
Price/Sales (ttm) 0.01
Price/Book (mrq) 0.64
Enterprise Value/Revenue 0.14
Enterprise Value/EBITDA 4.06
Overview
Shares outstanding 3.12B
Float 1.34B
Shares short -
% Held by insiders -
% Held by institutions 0.68%
Average volume (10 days) 60
Average volume (90 days) 1.62K
Price summary
52-Week low 1.69
52-Week high 2.37
Beta 0.6
50-Day moving average 2.27
200-Day moving average 2.17
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2024
Profitability
Profit margin 0.01%
Operating margin 0.04%
Operational effectiveness
Return on assets 0.03%
Return on equity 0.08%
Income Statement
Revenue (ttm) 71.95B
Revenue per share (ttm) 184.32
Quarterly revenue growth (yoy) 0.01%
Gross profit (ttm) 5.21B
EBITDA 24.14B
Net income to common (ttm) 895.03M
Diluted EPS (ttm) 0.29
Quarterly earnings growth (yoy) 0.04%
Balance Sheet
Total cash (mrq) 6.1B
Total cash per share (mrq) 15.64
Total debt (mrq) 8.88B
Total Debt/Equity (mrq) 52.89
Current ratio (mrq) 1.41%
Book value per share (mrq) 3.35
Cash Flow
Cash flow statement 1.77B
Levered free cash flow (LFCF) -38.89M
